Evidence-based pharmacological treatment of generalized anxiety disorder.

Baldwin, David S; Waldman, Sarah; Allgulander, Christer

Baldwin, David S; Waldman, Sarah; Allgulander, Christer.

Affiliation

Baldwin DS; Clinical Neuroscience Division, School of Medicine, University of Southampton, UK. dsb1@soton.ac.uk

Int J Neuropsychopharmacol ; 14(5): 697-710, 2011 Jun.

Article in En | MEDLINE | ID: mdl-21211105

Subject(s)

Antidepressive Agents/therapeutic use; Anxiety Disorders/drug therapy; Dopamine Uptake Inhibitors/therapeutic use; Evidence-Based Medicine; Selective Serotonin Reuptake Inhibitors/therapeutic use; Antidepressive Agents/adverse effects; Dopamine Uptake Inhibitors/adverse effects; Female; Humans; Male; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors/adverse effects; Stress Disorders, Traumatic, Acute/drug therapy; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anxiety Disorders / Selective Serotonin Reuptake Inhibitors / Dopamine Uptake Inhibitors / Evidence-Based Medicine / Antidepressive Agents Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Int J Neuropsychopharmacol Journal subject: NEUROLOGIA / PSICOFARMACOLOGIA Year: 2011 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google